Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
Christopher Teng, cataract and glaucoma expert, named new chair of Department of Ophthalmology & Visual Sciences – UMass Chan Medical School
Christopher Teng, cataract and glaucoma expert, named new chair of Department of Ophthalmology & Visual Sciences UMass Chan Medical School Source: Author: | Date: 2024-09-26 07:00:00 Source: Author: | Date: 2024-09-26 07:00:00
Embracing generative AI in ophthalmology – British Journal of Ophthalmology
Embracing generative AI in ophthalmology British Journal of Ophthalmology Source: Author: | Date: 2024-09-20 12:20:00 Source: Author: | Date: 2024-09-20 12:20:00
The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: Report 17, a risk factor model for posterior capsule rupture | Eye – Nature
The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: Report 17, a risk factor model for posterior capsule rupture | Eye Nature Source: Author: | Date: 2024-09-19 07:00:00 Source: Author: | Date: 2024-09-19 07:00:00
CU Ophthalmology Researcher Awarded Funding to Further Study Uveitis and Ocular Inflammation – CU Anschutz newsroom
CU Ophthalmology Researcher Awarded Funding to Further Study Uveitis and Ocular Inflammation CU Anschutz newsroom Source: Author: | Date: 2024-09-09 07:00:00 Source: Author: | Date: 2024-09-09 07:00:00
Ocular Therapeutix Enrolls First Patient in Phase 3 Wet AMD Study
Ocular Therapeutix announced that the first patients have been enrolled in its Phase 3 SOL-R clinical trial. This study aims to assess the repeat dosing of AXPAXLI™ (axitinib intravitreal implant, also known as OTX-TKI) for treating wet age-related macular degeneration…
Dr. Allen C. Ho Appointed Chairman of Alcon Research Institute
Alcon announced that Allen C. Ho, MD, will join the Alcon Research Institute’s (ARI) Executive Committee as chairman in October. The executive committee has overseen ARI’s mission to expand the frontiers of vision sciences globally since its founding in 1981,…
Researchers Discover Potential Therapeutic Target for Dry AMD
Researchers from the National Institutes of Health (NIH) have made a significant breakthrough in understanding the dysfunction associated with waste removal in the retina, offering new insights into dry age-related macular degeneration (AMD). A recent report from NIH and Johns…
GLP1RAs Linked to Higher DR Progression Risk vs. SGLT2is
A new study published online July 19 in Diabetes, Obesity and Metabolism has highlighted significant concerns regarding the treatment of diabetic retinopathy (DR) in patients with diabetes. The research indicates that treatment with glucagon-like peptide 1 receptor agonists (GLP1RAs) is…
Link Between Proteins in Tears and Pain After Eye Surgery
In a study published in the Journal of Proteome Research, researchers from Oregon Health & Science University (OHSU) have identified a connection between specific proteins found in patients’ tears and persistent pain experienced months after eye surgery. This discovery could…
Nicox Concludes U.S. Recruitment for Phase 3 NCX 470 Trial
Nicox announced the recruitment and randomization of the final patient in the United States for its Denali Phase 3 trial of NCX 470. This milestone marks a significant step in evaluating the safety and efficacy of NCX 470 for patients…